Novel insights in pharmacogenetics of drug response in Parkinson's disease

被引：0
作者：
El Arbouw, Maurits [1 ,2 ]
Guchelaar, Henk-Jan [3 ]
Egberts, Toine C. G. [1 ,2 ]
机构：
[1] Univ Med Ctr Utrecht, NL-3508 GA Utrecht, Netherlands
[2] Univ Utrecht, UIPS, Utrecht, Netherlands
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
PHARMACOGENOMICS | 2010年 / 11卷 / 02期
关键词：
L-DOPA; INDUCED DYSKINESIA; POLYMORPHISM; LEVODOPA; ROPINIROLE; HEALTH; 5-YEAR; BDNF;
D O I：
10.2217/PGS.09.175
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：127 / 129
页数：3
相关论文
共 23 条
[1]   Pharmacogenetics of antiparkinsonian drug treatment: a systematic review [J].
Arbouw, Maurits E. L. ;
van Vugt, Jeroen P. P. ;
Egberts, Toine C. G. ;
Guchelaar, Henk-Jan .
PHARMACOGENOMICS, 2007, 8 (02) :159-176
[2]   Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease [J].
Arbouw, Maurits E. L. ;
Movig, Kris L. L. ;
Egberts, Toine C. G. ;
Poels, Petra J. E. ;
van Vugt, Jeroen P. P. ;
Wessels, Judith A. M. ;
van der Straaten, R. J. H. M. ;
Neef, Cees ;
Guchelaar, Henk-Jan .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (12) :1245-1251
[3]   Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism [J].
Chase, TN ;
Oh, JD .
TRENDS IN NEUROSCIENCES, 2000, 23 (10) :S86-S91
[4]   Metabotropic glutamate receptors in the basal ganglia motor circuit [J].
Conn, PJ ;
Battaglia, G ;
Marino, MJ ;
Nicoletti, F .
NATURE REVIEWS NEUROSCIENCE, 2005, 6 (10) :787-798
[5]   BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease [J].
Foltynie, T. ;
Cheeran, B. ;
Williams-Gray, C. H. ;
Edwards, M. J. ;
Schneider, S. A. ;
Weinberger, D. ;
Rothwell, J. C. ;
Barker, R. A. ;
Bhatia, K. P. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (02) :141-144
[6]   Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease [J].
Fumagalli, F ;
Racagni, G ;
Riva, MA .
PHARMACOGENOMICS JOURNAL, 2006, 6 (02) :95-104
[7]   Hallucinosis in idiopathic Parkinson's disease [J].
Graham, JM ;
Grunewald, RA ;
Sagar, HJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (04) :434-440
[8]   Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations [J].
Jankovic, J .
MOVEMENT DISORDERS, 2005, 20 :S11-S16
[9]   Neuroproteomics: Expression profiling of the brain's proteomes in health and disease [J].
Kim, SI ;
Voshol, H ;
van Oostrum, J ;
Hastings, TG ;
Cascio, M ;
Glucksman, MJ .
NEUROCHEMICAL RESEARCH, 2004, 29 (06) :1317-1331
[10]   Pharmacogenetics of antidepressants and antipsychotics:: the contribution of allelic variations to the phenotype of drug response [J].
Kirchheiner, J ;
Nickchen, K ;
Bauer, M ;
Wong, ML ;
Licinio, J ;
Roots, I ;
Brockmöller, J .
MOLECULAR PSYCHIATRY, 2004, 9 (05) :442-473
123